Peter Greenleaf insider trades
Open-market stock purchases and sales by Peter Greenleaf, Director at Pelthos Therapeutics Inc, from SEC Form 4 filings since Mar 3, 2014.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $18.5K |
| Jul 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $2.3K |
| Apr 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $8.6K |
| Apr 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $8.1K |
| Mar 2, 2026 | AUPH Aurinia Pharmaceuticals Inc | Sold (not open market) | $1.4M |
| Feb 27, 2026 | AUPH Aurinia Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 27, 2026 | AUPH Aurinia Pharmaceuticals Inc | Bought (not open market) | — |
| Feb 20, 2026 | AUPH Aurinia Pharmaceuticals Inc | Sold (not open market) | $1.4M |
| Jan 2, 2026 | AUPH Aurinia Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 2, 2026 | AUPH Aurinia Pharmaceuticals Inc | Sold (not open market) | $1.8M |
Companies traded
- PTHS Pelthos Therapeutics Inc: 4 sales, last Jul 2, 2026
- AUPH Aurinia Pharmaceuticals Inc: 2 buys, 6 sales, last Mar 2, 2026
- ATRS Antares Pharma, Inc: other filings, last May 24, 2022
- BDSI Biodelivery Sciences International Inc: other filings, last Mar 22, 2022
- CERC Cerecor Inc: 1 buy, last Aug 7, 2019
- EYEG Eyegate Pharmaceuticals Inc: other filings, last Jul 27, 2018
- SCMP Sucampo Pharmaceuticals, Inc: 2 sales, last Feb 13, 2018
- MSTX Mast Therapeutics, Inc: other filings, last Jan 20, 2017
- MIRN Mirna Therapeutics, Inc: other filings, last Jun 29, 2016